146 related articles for article (PubMed ID: 2991580)
21. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
[TBL] [Abstract][Full Text] [Related]
22. N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection.
Jagdeo JM; Dufour A; Klein T; Solis N; Kleifeld O; Kizhakkedathu J; Luo H; Overall CM; Jan E
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437971
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of a membrane-bound population of group B coxsackieviruses.
Chatterjee NK; Samsonoff WA; Tuchowski C
J Virol; 1983 Feb; 45(2):832-41. PubMed ID: 6300437
[TBL] [Abstract][Full Text] [Related]
24. Modelling of the tertiary structure of coxsackievirus B3 from the structure of poliovirus and rhinovirus.
Liljas L; Lindberg AM; Pettersson U
Scand J Infect Dis Suppl; 1993; 88():15-24. PubMed ID: 8390718
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous Nuclear Ribonucleoprotein M Facilitates Enterovirus Infection.
Jagdeo JM; Dufour A; Fung G; Luo H; Kleifeld O; Overall CM; Jan E
J Virol; 2015 Jul; 89(14):7064-78. PubMed ID: 25926642
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
[TBL] [Abstract][Full Text] [Related]
27. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.
He Y; Chipman PR; Howitt J; Bator CM; Whitt MA; Baker TS; Kuhn RJ; Anderson CW; Freimuth P; Rossmann MG
Nat Struct Biol; 2001 Oct; 8(10):874-8. PubMed ID: 11573093
[TBL] [Abstract][Full Text] [Related]
28. A solid-phase assay of solubilized HeLa cell membrane receptors for binding group B coxsackieviruses and polioviruses.
Krah DL; Crowell RL
Virology; 1982 Apr; 118(1):148-56. PubMed ID: 6281966
[No Abstract] [Full Text] [Related]
29. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
[TBL] [Abstract][Full Text] [Related]
30. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.
Bergelson JM; Cunningham JA; Droguett G; Kurt-Jones EA; Krithivas A; Hong JS; Horwitz MS; Crowell RL; Finberg RW
Science; 1997 Feb; 275(5304):1320-3. PubMed ID: 9036860
[TBL] [Abstract][Full Text] [Related]
31. Membrane-bound virions of coxsackievirus B4: cellular localization, analysis of the genomic RNA, genome-linked protein, and effect on host macromolecular synthesis.
Chatterjee NK; Nejman C
Arch Virol; 1985; 84(1-2):105-18. PubMed ID: 2985028
[TBL] [Abstract][Full Text] [Related]
32. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors.
Bergelson JM; Modlin JF; Wieland-Alter W; Cunningham JA; Crowell RL; Finberg RW
J Infect Dis; 1997 Mar; 175(3):697-700. PubMed ID: 9041347
[TBL] [Abstract][Full Text] [Related]
33. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.
Shafren DR; Bates RC; Agrez MV; Herd RL; Burns GF; Barry RD
J Virol; 1995 Jun; 69(6):3873-7. PubMed ID: 7538177
[TBL] [Abstract][Full Text] [Related]
34. The role of B lymphocytes in coxsackievirus B3 infection.
Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
[TBL] [Abstract][Full Text] [Related]
35. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis.
Kishimoto C; Kurokawa M; Ochiai H
J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896
[TBL] [Abstract][Full Text] [Related]
36. Eclipse of coxsackievirus infectivity: the restrictive event for a non-fusing myogenic cell line.
Schultz M; Crowell RL
J Gen Virol; 1983 Aug; 64 (Pt 8)():1725-34. PubMed ID: 6308134
[TBL] [Abstract][Full Text] [Related]
37. A structural model for picornaviruses as suggested from an analysis of urea-degraded virions and procapsids of coxsackievirus B3.
Philipson L; Beatrice ST; Crowell RL
Virology; 1973 Jul; 54(1):69-79. PubMed ID: 4351615
[No Abstract] [Full Text] [Related]
38. Alteration of capsid proteins of coxsackievirus A13 by low ionic concentrations.
Cords CE; James CG; McLaren LC
J Virol; 1975 Feb; 15(2):244-52. PubMed ID: 163352
[TBL] [Abstract][Full Text] [Related]
39. Ribonucleic acid species of intracellular nucleocapsids and released virions of vesicular stomatitis virus.
Kiley MP; Wagner RR
J Virol; 1972 Aug; 10(2):244-55. PubMed ID: 4345058
[TBL] [Abstract][Full Text] [Related]
40. Effect of enterovirus infection on susceptibility of HeLa cells to Shigella flexneri invasivity.
Marchetti M; Conte MP; Longhi C; Nicoletti M; Seganti L; Orsi N
Acta Virol; 1992 Oct; 36(5):443-9. PubMed ID: 1364020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
